Design, development and evaluation of novel nanoemulsion formulations for transdermal potential of celecoxib
Tóm tắt
Từ khóa
Tài liệu tham khảo
E. Escibano, 2003, Assessment of diclofenac permeation with different formulations: anti-inflammatory study of a selected formula, Eur. J. Pharm. Sci., 19, 203, 10.1016/S0928-0987(03)00103-9
A. Gaurel, 1997, Celecoxib, anti-inflammatory, cyclo-oxygenase-2 inhibitor, Drug Future, 22, 711
K. Walters, 1989, Penetration Enhancers and their Use in Transdermal Therapeutic Systems, 197
D. Osborne, 1991, Microemulsions as topical delivery vehicles: in-vitro transdermal studies of a model hydrophilic drug, J. Pharm. Phamacol., 43, 450, 10.1111/j.2042-7158.1991.tb03511.x
M. Trotta, 1996, Influence of counter ions on the skin permeation of methotrexate from water-oil microemulsions, Pharm. Acta. Helv., 71, 135, 10.1016/0031-6865(96)00003-9
S. Shafiq, 2007, Design and development of ramipril nanoemulsion formulation: In vitro and in vivo assessment, J. Biomed. Nanotechnol., 3, 28, 10.1166/jbn.2007.008
S. Shafiq, 2007, Development and bioavailability assessment of ramipril nanoemulsion formulation, Eur. J. Pharm. Biopharm., 66, 227, 10.1016/j.ejpb.2006.10.014
M. Delgado-Charro, 1997, Delivery of a hydrophilic solute through the skin from novel microemulsion systems, Eur. J. Pharm. Biopharm., 43, 37, 10.1016/S0939-6411(96)00016-1
M. Kreilgaard, 2000, NMR characterization and transdermal drug delivery potentials of microemulsion systems, J. Control. Rel., 69, 421, 10.1016/S0168-3659(00)00325-4
P. Lee, 2003, Novel microemulsion enhancer formulation for simultaneous transdermal delivery of hydrophilic and hydrophobic drugs, Pharm. Res., 20, 264, 10.1023/A:1022283423116
M. Kreilgaard, 2001, Dermal pharmacokinetics of microemulsion formulations determined by in-vitro microdialysis, Pharm. Res., 18, 367, 10.1023/A:1011067300397
M. Kreilgaard, 2001, Influence of a microemulsion vehicle on cutaneous bioequivalence of a lipophilic model drug assessed by microdialysis and pharmacodynamics, Pharm. Res., 18, 593, 10.1023/A:1011068907416
M. Gasco, 1991, In-vitro permeation of zelaic acid from viscosized microemulsions, Int. J. Pharm., 69, 193, 10.1016/0378-5173(91)90361-Q
K. Kriwet, 1995, Diclofenac release from phospholipids drug systems and permeation through excised human stratum corneum, Int. J. Pharm., 125, 231, 10.1016/0378-5173(95)00130-B
S. Baboota, F. Shakeel, A. Ahuja, J. Ali, S. Shafiq and S. Ahmed, Development and validation of stability indicating HPLC method for analysis of Celecoxib in bulk drug and microemulsion formulations, <i>Acta Chromat.</i> (in press).
N. Van Abbe, 1975, Exaggerated exposure in topical irritancy and sensitization testing, J. Soc. Cosmet. Chem., 26, 173
C. Winter, 1965, Anti-inflammatory testing methods: Comparative evaluation of indomethacin and other agents, NSAID, 82, 190
M. Gosh, 2005, Fundamentals of Experimental Pharmacology, 192
D. Craig, 1995, An investigation into the mechanisms of self-emulsification using particle size analysis and low frequency dielectric spectroscopy, Int. J. Pharm., 114, 103, 10.1016/0378-5173(94)00222-Q
K. Kawakami, 2002, Microemulsion formulation for enhanced absorption of poorly soluble drugs I. Prescription design, J. Control. Rel., 81, 65, 10.1016/S0168-3659(02)00049-4
M. Lawrence, 2000, Microemulsion-based media as novel drug delivery systems, Adv. Drug Deliv. Rev., 45, 89, 10.1016/S0169-409X(00)00103-4
W. Warisnoicharoen, 2000, Light scattering investigations on dilute non-ionic oil-in-water microemulsions, AAPS PharmSci., 2, 10.1208/ps020212
L. Ping, 2005, Effect of combined use of nonionic surfactant on formation of oil-in-water microemulsions, Int. J. Pharm., 288, 27, 10.1016/j.ijpharm.2004.08.024
K. Shinoda, 1983, Phase Properties of Emulsions: PIT and HLB, 337
N. Kale, 1998, Studies on microemulsions using Brij-96 as surfactant and glycerin, ethylene glycol and propylene glycol as cosurfactants, Int. J. Pharm., 57, 87, 10.1016/0378-5173(89)90296-2